(Q33320772)

English

Incidence of reversible amenorrhea in women with breast cancer undergoing adjuvant anthracycline-based chemotherapy with or without docetaxel

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Incidence of reversible amenorrhea in women with breast cancer undergoing adjuvant anthracycline-based chemotherapy with or without docetaxel (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

7

object named as

Jacques Donnez

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

author name string

Martine Berliere

1

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Florence Dalenc

2

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Nathalie Malingret

3

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Anita Vindevogel

4

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Philippe Piette

5

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Henry Roche

6

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Michel Symann

8

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Joseph Kerger

9

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Jean-Pascal Machiels

10

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

language of work or name

0 references

publication date

21 February 2008

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

56

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

The effects of paclitaxel, dose density, and trastuzumab on treatment-related amenorrhea in premenopausal women with breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2287183

21 June 2018

Amenorrhea in premenopausal women after adjuvant chemotherapy for breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2287183

21 June 2018

Identifying menopause in breast cancer patients: considerations and implications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2287183

21 June 2018

Chemotherapy-induced amenorrhea from adjuvant breast cancer treatment: the effect of the addition of taxanes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2287183

21 June 2018

Preservation of fertility and ovarian function and minimalization of chemotherapy associated gonadotoxicity and premature ovarian failure: the role of inhibin-A and -B as markers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2287183

21 June 2018

Reproduction post-chemotherapy in young cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2287183

21 June 2018

Is chemotherapy alone adequate for young women with oestrogen-receptor-positive breast cancer?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2287183

21 June 2018

Prevention of gonadal damage during cytotoxic therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2287183

21 June 2018

Amenorrhea induced by adjuvant chemotherapy in early breast cancer patients: prognostic role and clinical implications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2287183

21 June 2018

Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2287183

21 June 2018

Mechanism of action of adjuvant chemotherapy in early breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2287183

21 June 2018

The magnitude of endocrine effects of adjuvant chemotherapy for premenopausal breast cancer patients. The International Breast Cancer Study Group.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2287183

21 June 2018

Incidence of chemotherapy-induced, long-term amenorrhea in patients with breast carcinoma age 40 years and younger after adjuvant anthracycline and taxane

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-56

21 January 2018

Incidence and prognostic impact of amenorrhea during adjuvant therapy in high-risk premenopausal breast cancer: analysis of a National Cancer Institute of Canada Clinical Trials Group Study--NCIC CTG MA.5.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-56

21 January 2018

Prognostic impact of amenorrhoea after adjuvant chemotherapy in premenopausal breast cancer patients with axillary node involvement: results of the International Breast Cancer Study Group (IBCSG) Trial VI.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-56

21 January 2018

Chemotherapy-induced amenorrhea: influence on disease-free survival and overall survival in receptor-positive premenopausal early breast cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2287183

31 October 2018

Prognostic effect of amenorrhoea and elevated serum gonadotropin levels induced by adjuvant chemotherapy in premenopausal node-positive breast cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/18291033

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cyclophosphamide-Induced Ovarian Failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/18291033

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CONTROLLED TRIAL OF ADJUVANT CHEMOTHERAPY WITH MELPHALAN FOR BREAST CANCER

1 reference

https://pubmed.ncbi.nlm.nih.gov/18291033

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immediate and long-term toxicity of adjuvant chemotherapy regimens containing doxorubicin in trials at M.D. Anderson Hospital and Tumor Institute

1 reference

https://pubmed.ncbi.nlm.nih.gov/18291033

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evidence of a castration-mediated effect of adjuvant cytotoxic chemotherapy in premenopausal breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18291033

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term sequelae from adjuvant chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18291033

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adjuvant cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer: the results of 20 years of follow-up

1 reference

https://pubmed.ncbi.nlm.nih.gov/18291033

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized trial of intensive cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women with node-positive breast cancer. National Cancer Institute of Canada Cli

1 reference

https://pubmed.ncbi.nlm.nih.gov/18291033

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic impact of amenorrhoea after adjuvant chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18291033

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ovarian overstimulation and cystic formation in premenopausal tamoxifen exposure: comparison between tamoxifen-treated and nontreated breast cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/18291033

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemotherapy-induced amenorrhea in early breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18291033

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sequential adjuvant epirubicin-based and docetaxel chemotherapy for node-positive breast cancer patients: the FNCLCC PACS 01 Trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/18291033

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The rates of chemotherapy-induced amenorrhea in patients treated with adjuvant doxorubicin and cyclophosphamide followed by a taxane

1 reference

https://pubmed.ncbi.nlm.nih.gov/18291033

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Premature ovarian failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/18291033

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1471-2407-8-56

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33320772&oldid=2195239760"